samedan logo
 
 
 
spacer
home > ebr > winter 2003 > in conversation with mary harney
PUBLICATIONS
European Biopharmaceutical Review

In conversation with Mary Harney

Mary Harney is the Irish Deputy Prime Minister and Minister for Enterprise Trade and Employment. She has had a direct hand in driving Ireland's recent impressive science research foundation programmes, identified as critical if Ireland was to underpin an emerging biotechnology industry on the back of decades of inward investment in pharmaceutical manufacturing expertise. A Tainiste, to give Mrs Harney her true political title in Ireland, is equally outspoken on the importance of knowledge-based industry - and biotechnology in particular - to future European economic growth along with the need for political will to replace rhetoric at the highest level. As incoming President of the EU Competitiveness Council, which oversees the EU's life sciences biotechnology strategy, Mrs Harney represented the most relevant and senior of political commentators to bring the political message at the Opening Plenary session of the CORDIA-EuropaBio Convention in December 2003.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Ireland Makes its Mark in Europe in the Opening Session of the Inaugural CORDIA-EuropaBio Convention, Vienna, December 2003

By Dr Helen Abbott, Chair Editorial Board of EBR and Member of Executive Steering Group, CORDIA-EuropaBio Convention 2003

spacer
Mary Harney
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Joining forces against SARS-CoV-2

Laupheim, Germany and Milford, MA, USA, October 08, 2020 - Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced an agreement to serve as CDMO partner for BioNTech. As an initial project, Rentschler Biopharma will be responsible for key aspects of cGMP (current good manufacturing practice) drug substance manufacturing of BNT162b2, the mRNA-based vaccine against SARS-CoV-2 that is being developed by Pfizer and BioNTech, and is currently in a global Phase 3 clinical trial.
More info >>

White Papers

Environmental Factors in Data Centres

Dycem

In addition to temperature and humidity, there are many more constraints in the environment that increase failure rates, explains Emilio Sapiņa of Secure Techincal Rooms.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement